Cardiac cell therapy: where we've been, where we are, and where we should be headed

K Malliaras, E Marban - British medical bulletin, 2011 - academic.oup.com
Introduction Stem cell therapy has emerged as a promising strategy for the treatment of
ischemic cardiomyopathy. Sources of data Multiple candidate cell types have been used in …

Cardiac cell therapy: Where weve been, where we are, and where we should be headed

K Malliaras, E Marbán - British Medical Bulletin, 2011 - jhu.pure.elsevier.com
Introduction: Stem cell therapy has emerged as a promising strategy for the treatment of
ischemic cardiomyopathy. Sources of data: Multiple candidate cell types have been used in …

Cardiac cell therapy: Where weve been, where we are, and where we should be headed

K Malliaras, E Marbán - British Medical Bulletin, 2011 - pure.johnshopkins.edu
Introduction: Stem cell therapy has emerged as a promising strategy for the treatment of
ischemic cardiomyopathy. Sources of data: Multiple candidate cell types have been used in …

[PDF][PDF] Cardiac cell therapy: where we've been, where we are, and where we should be headed

K Malliaras, E Marban - British Medical Bulletin, 2011 - Citeseer
Growing points/areas timely for developing research: This overview of the field leaves us
with cautious optimism, while motivating a search for more effective delivery methods, better …

Cardiac cell therapy: where we've been, where we are, and where we should be headed.

K Malliaras, E Marbán - British Medical Bulletin, 2011 - europepmc.org
Multiple candidate cell types have been used in preclinical animal models and in clinical
trials to repair or regenerate the injured heart either directly (through formation of new …

[引用][C] Cardiac cell therapy: where we've been, where we are, and where we should be headed

K Malliaras, E Marban - British Medical Bulletin, 2011 - cir.nii.ac.jp
Cardiac cell therapy: where we've been, where we are, and where we should be headed | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

[HTML][HTML] Cardiac cell therapy: where we've been, where we are, and where we should be headed

K Malliaras, E Marbán - British Medical Bulletin, 2011 - ncbi.nlm.nih.gov
Growing points/areas timely for developing research: This overview of the field leaves us
with cautious optimism, while motivating a search for more effective delivery methods, better …

[引用][C] Cardiac cell therapy: where we've been, where we are, and where we should be headed

K MALLIARAS, E MARBAN - British medical bulletin, 2011 - pascal-francis.inist.fr
Cardiac cell therapy: where we've been, where we are, and where we should be headed
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …

Cardiac cell therapy: where we've been, where we are, and where we should be headed

K Malliaras, E Marbán - British medical bulletin, 2011 - pubmed.ncbi.nlm.nih.gov
Introduction Stem cell therapy has emerged as a promising strategy for the treatment of
ischemic cardiomyopathy. Sources of data Multiple candidate cell types have been used in …

Cardiac cell therapy: where we've been, where we are, and where we should be headed.

K Malliaras, E Marbán - British Medical Bulletin, 2011 - search.ebscohost.com
Introduction Stem cell therapy has emerged as a promising strategy for the treatment of
ischemic cardiomyopathy. Sources of data Multiple candidate cell types have been used in …